FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 461 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Jimmy Carter Signed This Treaty Demanding An End To Violence Against... May 7, 2021 FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer May 10, 2018 Discovery of Tumor Suppressor Suggests New Cancer Treatment Strategies May 14, 2021 Tipifarnib Demonstrates Encouraging Efficacy in Patients with Recurrent and/or Metastatic HNSCC... April 21, 2021 Load more HOT NEWS Nivolumab Demonstrates Clinical Benefits in a Statistically Evaluable Number of Patients... Insights Into the Biology of Response and Resistance to MAPK Pathway... Coffee Shop Owner Runs Competitor’s Business For Free After Hearing He... Trastuzumab Deruxtecan Prolongs OS in Second-Line Treatment for Patients with HER2-positive...
